BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 26537052)

  • 1. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons.
    Boyle PA; Yu L; Nag S; Leurgans S; Wilson RS; Bennett DA; Schneider JA
    Neurology; 2015 Dec; 85(22):1930-6. PubMed ID: 26537052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral amyloid angiopathy pathology and cognitive domains in older persons.
    Arvanitakis Z; Leurgans SE; Wang Z; Wilson RS; Bennett DA; Schneider JA
    Ann Neurol; 2011 Feb; 69(2):320-7. PubMed ID: 21387377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
    Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
    JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of neuropathology to cognition in persons without cognitive impairment.
    Bennett DA; Wilson RS; Boyle PA; Buchman AS; Schneider JA
    Ann Neurol; 2012 Oct; 72(4):599-609. PubMed ID: 23109154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of neuropathology with cognitive decline among older persons without dementia.
    Boyle PA; Yu L; Wilson RS; Schneider JA; Bennett DA
    Front Aging Neurosci; 2013; 5():50. PubMed ID: 24058343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Much of late life cognitive decline is not due to common neurodegenerative pathologies.
    Boyle PA; Wilson RS; Yu L; Barr AM; Honer WG; Schneider JA; Bennett DA
    Ann Neurol; 2013 Sep; 74(3):478-89. PubMed ID: 23798485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinico-Neuropathological Findings in the Oldest Old from the Georgia Centenarian Study.
    Tanprasertsuk J; Johnson EJ; Johnson MA; Poon LW; Nelson PT; Davey A; Martin P; Barbey AK; Barger K; Wang XD; Scott TM
    J Alzheimers Dis; 2019; 70(1):35-49. PubMed ID: 31177211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capillary cerebral amyloid angiopathy in Alzheimer's disease: association with allocortical/hippocampal microinfarcts and cognitive decline.
    Hecht M; Krämer LM; von Arnim CAF; Otto M; Thal DR
    Acta Neuropathol; 2018 May; 135(5):681-694. PubMed ID: 29574591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease.
    Ringman JM; Sachs MC; Zhou Y; Monsell SE; Saver JL; Vinters HV
    JAMA Neurol; 2014 Jul; 71(7):878-83. PubMed ID: 24797962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
    Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
    Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies.
    Schneider JA; Arvanitakis Z; Yu L; Boyle PA; Leurgans SE; Bennett DA
    Brain; 2012 Oct; 135(Pt 10):3005-14. PubMed ID: 23065790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
    Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
    Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vulnerability to stress, anxiety, and development of dementia in old age.
    Wilson RS; Begeny CT; Boyle PA; Schneider JA; Bennett DA
    Am J Geriatr Psychiatry; 2011 Apr; 19(4):327-34. PubMed ID: 21427641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral Amyloid Angiopathy and Neuritic Plaque Pathology Correlate with Cognitive Decline in Elderly Non-Demented Individuals.
    Malek-Ahmadi M; Chen K; Perez SE; Mufson EJ
    J Alzheimers Dis; 2019; 67(1):411-422. PubMed ID: 30594928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology.
    Arvanitakis Z; Grodstein F; Bienias JL; Schneider JA; Wilson RS; Kelly JF; Evans DA; Bennett DA
    Neurology; 2008 Jun; 70(23):2219-25. PubMed ID: 18519870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microinfarct pathology, dementia, and cognitive systems.
    Arvanitakis Z; Leurgans SE; Barnes LL; Bennett DA; Schneider JA
    Stroke; 2011 Mar; 42(3):722-7. PubMed ID: 21212395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology.
    Attems J; Quass M; Jellinger KA; Lintner F
    J Neurol Sci; 2007 Jun; 257(1-2):49-55. PubMed ID: 17306303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Braak Stage, Cerebral Amyloid Angiopathy, and Cognitive Decline in Early Alzheimer's Disease.
    Malek-Ahmadi M; Perez SE; Chen K; Mufson EJ
    J Alzheimers Dis; 2020; 74(1):189-197. PubMed ID: 31985469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lewy body pathology modifies risk factors for cerebral amyloid angiopathy when comorbid with Alzheimer's disease pathology.
    Pillai JA; Bena J; Tousi B; Rothenberg K; Keene CD; Leverenz JB
    Alzheimers Dement; 2024 Apr; 20(4):2564-2574. PubMed ID: 38353367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical Thickness and Its Association with Clinical Cognitive and Neuroimaging Markers in Cerebral Amyloid Angiopathy.
    Subotic A; McCreary CR; Saad F; Nguyen A; Alvarez-Veronesi A; Zwiers AM; Charlton A; Beaudin AE; Ismail Z; Pike GB; Smith EE
    J Alzheimers Dis; 2021; 81(4):1663-1671. PubMed ID: 33998545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.